Atlas Trials

Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection

Clinical trial NCT03352349 · UNKNOWN

Trial details

NCT number
NCT03352349
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Portal Vein Pressure
Start date
2017-12-01
Primary completion
2018-10-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.